Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Hepatitis Diagnostic Tests Market Forecast: Value Set To Climb From $5.21 Billion To $6.72 Billion
The hepatitis diagnostic tests market has seen robust growth in its size over recent years. It is projected to increase from $4.93 billion in 2025 to $5.21 billion in 2026, at a compound annual growth rate (CAGR) of 5.7%. Historically, this growth can be attributed to the expansion of hepatitis screening programs, a rise in laboratory testing volumes, greater public awareness of viral hepatitis, improved access to diagnostic infrastructure, and the availability of standardized testing protocols.
The hepatitis diagnostic tests market size is projected to experience substantial growth in the upcoming years. It is forecast to expand to $6.72 billion by 2030, achieving a compound annual growth rate (CAGR) of 6.6%. The expansion during this period can be ascribed to a rising demand for decentralized diagnostics, increased investments in advanced molecular testing, the broadening of home-based testing solutions, a stronger emphasis on early disease detection, and greater acceptance in low-resource environments. Significant trends expected during the forecast period involve the growing adoption of rapid diagnostic tests, an increasing application of molecular diagnostic technologies, the expanding integration of automated laboratory systems, the proliferation of point-of-care testing solutions, and an enhanced focus on timely and precise diagnoses.
Get A Free Sample Report With In-Depth Market Insights:
Hepatitis Diagnostic Tests Market Growth Momentum: What Factors Are Shaping Demand?
The increasing volume of blood transfusions and donations is anticipated to boost the growth of the hepatitis diagnostic test market in the future. These interconnected processes involve individuals voluntarily giving blood, which is then collected, screened, and subsequently given to patients needing extra blood components to address medical conditions or replenish blood lost from surgeries, accidents, or illnesses. Hepatitis diagnostic tests play a crucial role in comprehensively screening blood prior to both donation and transfusion, thereby ensuring patient safety. For example, in August 2023, the Royal College of Pathologists, a UK-based organization, reported that blood transfusion is the most common procedure for hospitalized patients, with almost 2 million blood components issued and transfused yearly in England, costing more than £300 ($390.69) million. Consequently, the increasing incidence of blood transfusions and donations fuels the demand in the hepatitis diagnostic test market.
Hepatitis Diagnostic Tests Market Segmentation And Category Overview
The hepatitis diagnostic tests market covered in this report is segmented –
1) By Test Type: Blood Tests, Imaging Tests, Liver Biopsy
2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests (RDTs), Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Test (INAAT), Other Technologies
3) By End User: Hospitals, Diagnostic Laboratories, Blood Bank, Other End Users
Subsegments:
1) By Blood Tests: Serological Tests, Polymerase Chain Reaction (PCR) Tests, Enzyme-Linked Immunosorbent Assays (ELISA)
2) By Imaging Tests: Ultrasound, Computed Tomography (CT), Magnetic Resonance Imaging (MRI)
3) By Liver Biopsy: Percutaneous Biopsy, Transjugular Biopsy, Laparoscopic Biopsy
Hepatitis Diagnostic Tests Market Trends: What’s Defining The Industry’s Next Phase?
Leading companies within the hepatitis diagnostic test market are dedicated to developing innovative automated immunoassays, such as Elecsys HCV Duo, to deliver dependable customer service. These Elecsys HCV Duo Automated immunoassays are laboratory methods that employ automation systems and specialized instruments to conduct all phases of the immunoassay process, including handling samples, mixing reagents, incubation, detection, and calculating results. For example, in July 2023, Roche Diagnostics India, an India-based biotechnology research firm, launched Elecsys HCV Duo. It represents India’s first commercially available fully automated immunoassay that allows for the simultaneous and independent assessment of hepatitis C virus (HCV) antigen and antibody levels using a single human plasma or serum sample. This also enables single specimen testing and streamlines the diagnostic algorithm, which reduces the number of visits needed for further tests and can ease the burden of testing on the healthcare system.
Hepatitis Diagnostic Tests Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the hepatitis diagnostic tests market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Roche Diagnostics, Quest Diagnostics Incorporated, Grifols S.A, Hologic Inc., BioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., SD Biosensor Co. Ltd., QIAGEN N.V., DiaSorin S.p.A., Randox Laboratories Ltd., Luminex Corporation, Fujirebio Diagnostics Inc., Trivitron Healthcare Private Limited, Trinity Biotech plc, MP Biomedicals LLC, R-Biopharm AG, Creative Diagnostics, InBios International Inc., Dia.Pro Diagnostic Bioprobes srl, DIALAB GmbH
View The Full Hepatitis Diagnostic Tests Market Report:
Hepatitis Diagnostic Tests Market Regional Analysis: Which Geography Leads On Revenue?
North America was the largest region in the hepatitis diagnostic tests market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis diagnostic tests market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
